IL6 and type 2 diabetes mellitus: Bullo et al. conducted a cross-sectional study in 511 older men and women with type 2 diabetes or multiple CVD risk factors that were recruited for the PREDIMED trial [19] and found that levels of tumor necrosis factor (TNF) and IL-6 were higher in the highest quartile of GI at baseline.